Convatec CEO to take medical leave of absence.


Convatec’s chief executive Karim Bitar is to take a medical leave of absence from the company, the medical products and technologies group announced on Monday.

  • Convatec Group
  • 04 August 2025 07:24:15
ConvaTec Group

Source: Sharecast

Chief financial officer Jonny Mason will step in to become interim CEO, and be replaced by group financial controller Fiona Ryder, while the company waits for Bitar’s return.

Bitar, who has been CEO at Convatec since 2019, is the former boss of animal genetics company Genus, and prior to that spent 15 years working for American pharma giant Eli Lilly.

In Convatec's interim results last week, Batir said the company was "well-positioned to deliver our medium-term targets" after growing revenues and operating profits by 6% and 20.1% in the first half, respectively.

Batir said the growth targets, which include double-digit compound annual growth in EPS and free cash flow to equity, "will be driven by our leading positions in structurally growing markets, strongest-ever innovation pipeline and clear focus on execution excellence by our dedicated team of over 10,000 colleagues worldwide".


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 20.68 ( 0.23 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.